Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (391-400 of 456) with videos related to

Pageof 46
Sort By:
The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.
The Oncologist|November 6, 2008
Racism in the chemotherapy infusion unit: a nurse's storyLidia Schapira, Leah Gordon-Rowe, Rosalba Martignetti, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
AntimetabolitesJ L Grem, C H Takimoto, P Multani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.
The Journal of Clinical Investigation|September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?B A Chabner, C J Allegra, G A Curt, et al.
Cancer|August 1, 1978
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphomaB A Chabner, R E Johnson, R C Young, et al.
The Oncologist|April 17, 2003
Trust violated: analgesics for addictsRichard T Penson, Catherine Nunn, Jerry Younger, et al.
Cancer Treatment Reports|September 1, 1977
Sequential staging in non-Hodgkin's lymphomaB A Chabner, R E Johnson, V T DeVita, et al.
Cancer Treatment Reports|September 1, 1977
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combinationR C Young, R E Johnson, G P Canellos, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
Pageof 46

Showing results (391-400 of 456) with videos related to

Sort By:
Pageof 46
The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.
The Oncologist|November 6, 2008
Racism in the chemotherapy infusion unit: a nurse's storyLidia Schapira, Leah Gordon-Rowe, Rosalba Martignetti, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
AntimetabolitesJ L Grem, C H Takimoto, P Multani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.
The Journal of Clinical Investigation|September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?B A Chabner, C J Allegra, G A Curt, et al.
Cancer|August 1, 1978
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphomaB A Chabner, R E Johnson, R C Young, et al.
The Oncologist|April 17, 2003
Trust violated: analgesics for addictsRichard T Penson, Catherine Nunn, Jerry Younger, et al.
Cancer Treatment Reports|September 1, 1977
Sequential staging in non-Hodgkin's lymphomaB A Chabner, R E Johnson, V T DeVita, et al.
Cancer Treatment Reports|September 1, 1977
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combinationR C Young, R E Johnson, G P Canellos, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
Pageof 46